ライフサイエンスコーパス: alveolar hemorrhage

1 ment of patients with major renal disease or alveolar hemorrhage.

2 20% hemosiderin-laden macrophages in diffuse alveolar hemorrhage.

3 nt respiratory distress syndrome and diffuse alveolar hemorrhage.

4 stem cell transplant recipients with diffuse alveolar hemorrhage.

5 the right upper pulmonary lobe suggestive of alveolar hemorrhage.

6 ssociated with pleural effusions and diffuse alveolar hemorrhage.

7 atory cell infiltration, alveolar edema, and alveolar hemorrhage.

8 ients required dialysis, and 52% had diffuse alveolar hemorrhage.

9 for engraftment syndrome and 15 for diffuse alveolar hemorrhage.

10 d inflammatory cell influx and minimal intra-alveolar hemorrhage.

11 o died 8 days after symptom onset, had intra-alveolar hemorrhage.

12 enhanced inflammatory cell influx and intra-alveolar hemorrhage.

13 hils, and extensive pulmonary vasculitis and alveolar hemorrhaging.

14 ., nasal crusting = 1 point) or major (e.g., alveolar hemorrhage = 3 points).

15 lure was pneumonia (41%) followed by diffuse alveolar hemorrhage (37%).

16 an intense vascular infiltration and diffuse alveolar hemorrhage 7 days after transplantation (n = 5)

17 scular (61 +/- 26 vs. 15 +/- 13 vessels) and alveolar hemorrhage (76 +/- 11% vs. 26 +/- 18% of alveol

18 mation, alveolar-capillary permeability, and alveolar hemorrhage after intra-tracheal lipopolysacchar

19 Except for diffuse alveolar hemorrhage and cerebral hemorrhage, bleeding is

20 Common histopathologic findings were intra-alveolar hemorrhage and edema in the lung, chronic or ac

21 Five of 26 patients with diffuse alveolar hemorrhage and four of 33 patients with pneumon

22 l margination, vacuolated endothelium, intra-alveolar hemorrhage and macro- and microvascular thrombo

23 in particular, indicated severe congestion, alveolar hemorrhage, and acute inflammatory infiltrate i

24 of lung injury (intra-alveolar edema, intra-alveolar hemorrhage, and capillary congestion).

25 cytotoxicity in vitro and lung edema, intra-alveolar hemorrhage, and mortality in mice receiving a l

26 interferonopathy, typically characterized by alveolar hemorrhage, arthritis, and nephritis.

27 this case implicate subclinical episodes of alveolar hemorrhage as the mechanism of interstitial lun

28 veolar-capillary alterations; however, intra-alveolar hemorrhages, bacterial deposition, and markers

29 Rationale: Diffuse alveolar hemorrhage (DAH) is a life-threatening manifest

30 Diffuse alveolar hemorrhage (DAH) is a rare yet serious and freq

31 Diffuse alveolar hemorrhage (DAH) is one noninfectious pulmonary

32 Diffuse alveolar hemorrhage (DAH) resulting from pulmonary capil

33 nhance the severity of lupus-induced diffuse alveolar hemorrhage (DAH), intraperitoneal pristane inje

34 ted by lung microvascular injury and diffuse alveolar hemorrhage (DAH).

35 LONIPCs manifest as diffuse alveolar hemorrhage (DAH, n=28), idiopathic pneumonia sy

36 ild-type strain caused high mortality, intra-alveolar hemorrhages, extensive alveolar septal sequestr

37 ing acute eosinophilic pneumonia and diffuse alveolar hemorrhage, have also been reported.

38 cause severe lung necrosis, pulmonary edema, alveolar hemorrhage, hemoptysis, and death, hallmark cli

39 nscription factor was associated with lethal alveolar hemorrhage in 55% of the Foxf1 +/- newborn mice

40 reduced vascular permeability and suppressed alveolar hemorrhage in an orthotopic transplant model fo

41 Classification of diffuse alveolar hemorrhage in children has been revised to incl

42 we discuss the changing concepts of diffuse alveolar hemorrhage in children in terms of an expanded

43 y hemosiderosis, the classic form of diffuse alveolar hemorrhage in children, is a diagnosis of exclu

44 se subsets, such as the greater frequency of alveolar hemorrhage in the severe disease group, were re

45 xcess endotoxin can cause the development of alveolar hemorrhage in this model.

46 stem cell transplant recipients with diffuse alveolar hemorrhage is better than previously reported,

47 ain for hemosiderin, indicating that diffuse alveolar hemorrhage is occurring.

48 in acute lung injury and suggests that intra-alveolar hemorrhage is the result of basement membrane d

49 thrombocytopenia triggered substantial intra-alveolar hemorrhage leading to profound anemia and respi

50 icroscopy demonstrated a marked reduction in alveolar hemorrhage, lung fluid accumulation, and inflam

51 nt respiratory distress syndrome and diffuse alveolar hemorrhage may mimic pneumonia of infectious et

52 or necrosis factor alpha were observed, with alveolar hemorrhage occurring in 4 of 12 of these mice b

53 llaritis, an immune-mediated form of diffuse alveolar hemorrhage often associated with systemic disea

54 Willebrand factor release and no evidence of alveolar hemorrhage or edema.

55 atment trials excluded patients with diffuse alveolar hemorrhage or severely impaired glomerular filt

56 anizing pneumonia, focal fibrosis, pulmonary alveolar hemorrhage, or a combination thereof.

57 .001), and the histological scores for intra-alveolar hemorrhage (P<0.05) and for capillary congestio

58 ntilation was associated with a reduction in alveolar hemorrhage, pulmonary edema, and lung inflammat

59 os, intrapulmonary hyphal proliferation, and alveolar hemorrhage were all greater after infection wit

60 in an 18-yr-old woman who developed diffuse alveolar hemorrhage while being treated with ATRA for ac

61 y euthanized by day 6 or 7 and had pulmonary alveolar hemorrhage with mononuclear infiltrates.

62 trongly considered in any child with diffuse alveolar hemorrhage without a cardiovascular cause.